These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 5881729)

  • 21. Normal child birth under ethionamide treatment.
    Bhatia JL; Raj B
    Indian J Chest Dis; 1966 Jul; 8(3):167-70. PubMed ID: 5927439
    [No Abstract]   [Full Text] [Related]  

  • 22. [Neuropsychiatric repercussions of antitubercular treatment with isoniazid, or isoniazid and ethionamide (apropos of 8 cases)].
    Bleandonu G; Boye J
    Ann Med Psychol (Paris); 1969 Jul; 2(2):201-26. PubMed ID: 5385334
    [No Abstract]   [Full Text] [Related]  

  • 23. Ethionamide, pyrazinamide and cycloserine in drug resistant cases.
    Narang RK; Singh SK
    Indian J Chest Dis; 1973 Jan; 15(1):16-20. PubMed ID: 4695462
    [No Abstract]   [Full Text] [Related]  

  • 24. [A comparative study on clinical efficacy of rifampicin (RFP), ethambutol (EB) and ethionamide (1321 TH) in retreatment of pulmonary tuberculosis. Report of the 13th series study part B].
    Kekkaku; 1972 May; 47(5):139-44. PubMed ID: 5042532
    [No Abstract]   [Full Text] [Related]  

  • 25. [Study on the adverse effects of secondary antituberculous drugs, with special reference to mental disorders induced by cycloserine and ethionamide].
    Ono K; Hashigami Y; Itonaga K; Aida Y; Fujino S
    Iryo; 1969 Jan; 23(1):85-91. PubMed ID: 5783221
    [No Abstract]   [Full Text] [Related]  

  • 26. Ethionamide-induced Pellagra.
    Gupta Y; Shah I
    J Trop Pediatr; 2015 Aug; 61(4):301-3. PubMed ID: 25828829
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of therapeutic efficacy and toxicity of ethionamide and prothionamide in Indian patients.
    Gupta DK; Mital OP; Agarwal MC; Kansal HM; Nath S
    J Indian Med Assoc; 1977 Jan; 68(2):25-9. PubMed ID: 326974
    [No Abstract]   [Full Text] [Related]  

  • 28. A comparison of regimens of ethionamide, pyrazinamide and cycloserine in re-treatment of patients with pulmonary tuberculosis.
    Bignall JR; Lind A; Rist N
    Bull Int Union Tuberc; 1969 Aug; 42():7-57. PubMed ID: 5004884
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical study of comparative evaluation of 1321 TH and 1314 TH].
    Sunahara S; Kawamori U; Kitamoto O; Gomi J; Yamasaki M
    Saishin Igaku; 1967 Sep; 22(9):2098-113. PubMed ID: 6082219
    [No Abstract]   [Full Text] [Related]  

  • 30. Efficacy and safety of sparfloxacin in combination with kanamycin and ethionamide in multidrug-resistant pulmonary tuberculosis patients: preliminary results.
    Singla R; Gupta S; Gupta R; Arora VK
    Int J Tuberc Lung Dis; 2001 Jun; 5(6):559-63. PubMed ID: 11409584
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparative study of 2 types of oral therapy of pulmonary tuberculosis (ethionamide and isoniazid, thiacetazone and isoniazid)].
    Chicou FJ; Hétrick G; Huet M; Radenac H; Rist N
    Bull World Health Organ; 1968; 39(5):731-69. PubMed ID: 4183287
    [No Abstract]   [Full Text] [Related]  

  • 32. [Trevintix in the treatment of tuberculous patients (tolerance evaluation)].
    Pregowski W; Zagórecka A
    Gruzlica; 1968; 37(1):39-42. PubMed ID: 5720036
    [No Abstract]   [Full Text] [Related]  

  • 33. [Action of ethionamide on the basic functions of the stomach and on small intestine motor activity].
    Petrenko VM; Lukatskiĭ RA; Groĭsman SD
    Vrach Delo; 1979 Nov; (11):49-52. PubMed ID: 524819
    [No Abstract]   [Full Text] [Related]  

  • 34. [Case of SIADH caused by ethionamide in a patient with pulmonary tuberculosis].
    Nakashita T; Motojima S
    Kekkaku; 2006 Dec; 81(12):731-5. PubMed ID: 17240918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparative studies of adverse effects of 1314TH and 1321TH 2].
    Gomi J; Aoyagi T; Oana M; Kawai T; Yamada Y
    Saishin Igaku; 1970 Dec; 25(12):2569-75. PubMed ID: 4923131
    [No Abstract]   [Full Text] [Related]  

  • 36. [Experimental and clinical evaluation of alpha-propyl-2-thioisonicotinamide (1321 TH)].
    Kawamori U; Soejima R; Tagawa K; Nagao T; Nozute H
    Saishin Igaku; 1967 Sep; 22(9):2066-72. PubMed ID: 4966175
    [No Abstract]   [Full Text] [Related]  

  • 37. [Secondary antitubercular drugs in the treatment of childhood tuberculosis].
    de Lacerda A
    Rev Port Pediatr Pueric; 1967 May; 30(5):149-56. PubMed ID: 4303078
    [No Abstract]   [Full Text] [Related]  

  • 38. [Centrilobular parenchymal necrosis of the liver. A contribution to the knowledge of drug induced lesions of the liver (author's transl)].
    Beckert W
    Zentralbl Allg Pathol; 1973; 117(3):219-26. PubMed ID: 4520112
    [No Abstract]   [Full Text] [Related]  

  • 39. [Side effects of ETA combined with INH and SM in the first antituberculous treatment of pulmonary tuberculosis].
    Sosnowski W; Rozniecki J; Kubiak Z; Pruszyńska S
    Gruzlica; 1968 Oct; 36(10):983-5. PubMed ID: 5710105
    [No Abstract]   [Full Text] [Related]  

  • 40. [Adverse effect of etiotropic agents in patients with tuberculosis].
    Mel'nik VP
    Vrach Delo; 1991 Jun; (6):89-91. PubMed ID: 1891867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.